Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Renal effects of insulin in man.
Quiñones-Galvan A, Ferrannini E. Quiñones-Galvan A, et al. J Nephrol. 1997 Jul-Aug;10(4):188-91. J Nephrol. 1997. PMID: 9377725 Review.
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension.
Quiñones-Galvan A, Pucciarelli A, Ciociaro D, Masoni A, Franzoni F, Natali A, Ferrannini E. Quiñones-Galvan A, et al. J Cardiovasc Pharmacol. 2002 Dec;40(6):916-21. doi: 10.1097/00005344-200212000-00013. J Cardiovasc Pharmacol. 2002. PMID: 12451325 Clinical Trial.
On the paradox insulin resistance/insulin hypersensitivity and obesity: two tales of the same history.
Guiducci L, Iervasi G, Quinones-Galvan A. Guiducci L, et al. Among authors: quinones galvan a. Expert Rev Cardiovasc Ther. 2014 Jun;12(6):637-42. doi: 10.1586/14779072.2014.910115. Expert Rev Cardiovasc Ther. 2014. PMID: 24846675
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E. Gastaldelli A, et al. Among authors: quinones galvan a. Diabetes. 2001 Aug;50(8):1807-12. doi: 10.2337/diabetes.50.8.1807. Diabetes. 2001. PMID: 11473042 Free article.
Metabolic effects of glucose-insulin infusions: myocardium and whole body.
Quiñones-Galvan A, Ferrannini E. Quiñones-Galvan A, et al. Curr Opin Clin Nutr Metab Care. 2001 Mar;4(2):157-63. doi: 10.1097/00075197-200103000-00013. Curr Opin Clin Nutr Metab Care. 2001. PMID: 11224662 Review.
Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans.
Quiñones-Galvan A, Sironi AM, Baldi S, Galetta F, Garbin U, Fratta-Pasini A, Cominacini L, Ferrannini E. Quiñones-Galvan A, et al. Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2928-32. doi: 10.1161/01.atv.19.12.2928. Arterioscler Thromb Vasc Biol. 1999. PMID: 10591671 Clinical Trial.
Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension.
Natali A, Quiñones Galvan A, Pecori N, Sanna G, Toschi E, Ferrannini E. Natali A, et al. Hypertension. 1998 Feb;31(2):632-6. doi: 10.1161/01.hyp.31.2.632. Hypertension. 1998. PMID: 9461233 Clinical Trial.
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension.
Natali A, Taddei S, Quiñones Galvan A, Camastra S, Baldi S, Frascerra S, Virdis A, Sudano I, Salvetti A, Ferrannini E. Natali A, et al. Circulation. 1997 Aug 5;96(3):849-55. doi: 10.1161/01.cir.96.3.849. Circulation. 1997. PMID: 9264492
Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects.
Catalano C, Muscelli E, Quiñones Galvan A, Baldi S, Masoni A, Gibb I, Torffvit O, Seghieri G, Ferrannini E. Catalano C, et al. Diabetes. 1997 May;46(5):868-75. doi: 10.2337/diab.46.5.868. Diabetes. 1997. PMID: 9133557
Renovascular hypertension and insulin sensitivity.
Natali A, Quiñones Galvan A, Arzilli F, Taddei S, Pecori N, Frascerra S, Salvetti A, Ferrannini E. Natali A, et al. Eur J Clin Invest. 1996 Jul;26(7):556-63. doi: 10.1046/j.1365-2362.1996.1740521.x. Eur J Clin Invest. 1996. PMID: 8864417
25 results
Jump to page
Feedback